Roche's Gazyvaro, a drug that can restore kidney function in people living with lupus nephritis, has been cleared for use by ...

J&J is predicting 2026 revenues will be between $99.5 billion and $100.5 billion, up from just over $94 billion in 2025.

Amazon has become the latest tech company to introduce an AI-powered assistant that is designed to provide health guidance ...

The WHO has been working over the past year to try to get the Trump administration to change course, and Director General ...

GSK gets an entry in the list with Exdensur (depemokimab), a twice-yearly injectable IL-5 inhibitor for severe asthma, which ...

Laboratory services leader adds pharma veteran to board. Lab services giant LabCorp appointed Novartis US President Victor ...

For example, we had the Elective Recovery Fund, its focus was clear – to incentivise extra activity and reduce waiting lists.